Add time:08/06/2019         Source:sciencedirect.com

The antiprotozoal drug 3a,4,5,6,7,7a‐hexahydro‐3‐(1‐methyl‐5‐nitro‐1 H‐imidazol‐2‐yl)‐1,2‐benzisoxazole (I), which exhibits activity against trypanosomiasis, is also antibacterial in vivo. Since the urine from a dog dosed with I showed a broader spectrum of antibacterial activity than I itself, metabolites from this urine were isolated and partially characterized. The metabolites were mono‐ and dihydroxy‐substituted species with the hydroxyl groups on carbons 4‐7 of the hexahy‐drobenzisoxazole ring. These observations led to the synthesis of several such hydroxy derivatives of I, and their properties fully supported the proposed positions of metabolic hydroxylation. One synthetic compound, the 6,7‐ cis‐dihydroxy compound, exhibited higher antibacterial activity against Salmonella schottmuelleri in mice and greater trypanocidal activity in vivo against Trypanosoma cruzi (Brazil strain) than I.

We also recommend Trading Suppliers and Manufacturers of 5-METHYL-1,2-BENZISOXAZOLE (cas 10531-77-8). Pls Click Website Link as below: cas 10531-77-8 suppliers